Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12306-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 08.07.2026. Verfasst von Shazia Gul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India. Hauptthemen laut MEDLINE: Doxorubicin, Exosomes, Drug Resistance, Neoplasm, Breast Neoplasms. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India.
- Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India. zargarma@gmail.com.
- Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India. waninh@yahoo.co.in.
Förderung
- Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi.
Zitieren
APA
Gul, S., Jan, J., Mohidin, R., Bhat, O. M., Dar, A. H., Zargar, M. A., & Wani, N. A. (2026). Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12306-8
Vancouver
Gul S, Jan J, Mohidin R, Bhat OM, Dar AH, Zargar MA, et al. Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12306-8
BibTeX
@article{Gul2026,
author = {Gul, Shazia and Jan, Jasmeena and Mohidin, Rumaisa and Bhat, Owais Mohmad and Dar, Abid Hamid and Zargar, Mohammad Afzal and Wani, Nissar Ahmad},
title = {Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12306-8}
}
EUVIMED